Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1957 1
1961 1
1962 1
1963 1
1964 1
1966 1
1968 3
1969 1
1970 8
1971 9
1972 2
1973 1
1974 2
1975 2
1976 3
1977 3
1978 1
1979 2
1980 2
1981 3
1982 5
1983 5
1984 2
1985 2
1986 3
1987 5
1988 5
1989 6
1990 8
1991 8
1992 16
1993 14
1994 15
1995 11
1996 27
1997 35
1998 35
1999 56
2000 73
2001 74
2002 91
2003 93
2004 129
2005 108
2006 113
2007 115
2008 135
2009 138
2010 129
2011 148
2012 131
2013 120
2014 119
2015 167
2016 167
2017 199
2018 214
2019 254
2020 294
2021 305
2022 302
2023 281
2024 283
2025 221
2026 118

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,291 results

Results by year

Filters applied: . Clear all
Page 1
Branched Chain Amino Acids: Beyond Nutrition Metabolism.
Nie C, He T, Zhang W, Zhang G, Ma X. Nie C, et al. Int J Mol Sci. 2018 Mar 23;19(4):954. doi: 10.3390/ijms19040954. Int J Mol Sci. 2018. PMID: 29570613 Free PMC article. Review.
Branched chain amino acids (BCAAs), including leucine (Leu), isoleucine (Ile), and valine (Val), play critical roles in the regulation of energy homeostasis, nutrition metabolism, gut health, immunity and disease in humans and animals. ...Current evidence supports B …
Branched chain amino acids (BCAAs), including leucine (Leu), isoleucine (Ile), and valine (Val), play critical roles in the regulatio …
Circulating Metabolites and Cardiovascular Disease in Asians with Chronic Kidney Disease.
Cai J, Chong CCY, Cheng CY, Lim CC, Sabanayagam C. Cai J, et al. Cardiorenal Med. 2023;13(1):301-309. doi: 10.1159/000533741. Epub 2023 Sep 5. Cardiorenal Med. 2023. PMID: 37669626 Free PMC article.
INTRODUCTION: Chronic kidney disease (CKD) is a growing public health problem, with significant burden of cardiovascular disease and mortality. ...CONCLUSION: In Chinese, Indian, and Malay participants with CKD, prevalent cardiovascular disease …
INTRODUCTION: Chronic kidney disease (CKD) is a growing public health problem, with significant burden of cardiovascular di …
Valsartan/hydrochlorothiazide.
Langtry HD, McClellan KJ. Langtry HD, et al. Drugs. 1999 May;57(5):751-5; discussion 756-8. doi: 10.2165/00003495-199957050-00008. Drugs. 1999. PMID: 10353300 Review.
Von Willebrand factor exacerbates heart failure through formation of neutrophil extracellular traps.
Mang G, Chen J, Sun P, Ma R, Du J, Wang X, Cui J, Yang M, Tong Z, Yan X, Wang D, Xie H, Chen Y, Yang Q, Kong Y, Jin J, Wu J, Zhang M, Yu B. Mang G, et al. Eur Heart J. 2024 Oct 5;45(37):3853-3867. doi: 10.1093/eurheartj/ehae517. Eur Heart J. 2024. PMID: 39165142 Free article.
Neutrophil extracellular traps (NETs) aggravate inflammation in various cardiovascular diseases; however, their function and mechanism of action in HF pathogenesis remain underexplored. ...
Neutrophil extracellular traps (NETs) aggravate inflammation in various cardiovascular diseases; however, their function and m …
Sacubitril/valsartan in cardiovascular disease: evidence to date and place in therapy.
Yandrapalli S, Khan MH, Rochlani Y, Aronow WS. Yandrapalli S, et al. Ther Adv Cardiovasc Dis. 2018 Aug;12(8):217-231. doi: 10.1177/1753944718784536. Epub 2018 Jun 19. Ther Adv Cardiovasc Dis. 2018. PMID: 29921166 Free PMC article. Review.
Cardiovascular (CV) disease is a major cause of morbidity and mortality in the developing and the developed world. ...Sacubitril/valsartan is a much-needed therapeutic advance in the avenue of CV disease....
Cardiovascular (CV) disease is a major cause of morbidity and mortality in the developing and the developed world. ...Sacubitr …
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.
Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A; VALUE trial group. Julius S, et al. Lancet. 2004 Jun 19;363(9426):2022-31. doi: 10.1016/S0140-6736(04)16451-9. Lancet. 2004. PMID: 15207952 Clinical Trial.
INTERPRETATION: The main outcome of cardiac disease did not differ between the treatment groups. Unequal reductions in blood pressure might account for differences between the groups in cause-specific outcomes. The findings emphasise the importance of prompt blood-pressure …
INTERPRETATION: The main outcome of cardiac disease did not differ between the treatment groups. Unequal reductions in blood pressure …
Antihypertensive therapies.
Smith RE, Ashiya M. Smith RE, et al. Nat Rev Drug Discov. 2007 Aug;6(8):597-8. doi: 10.1038/nrd2354. Nat Rev Drug Discov. 2007. PMID: 17821828 No abstract available.
Novel Therapies for the Treatment of Cardiovascular Disease.
Asbeutah AAA, Goldberger ZD. Asbeutah AAA, et al. Med Clin North Am. 2024 Sep;108(5):953-964. doi: 10.1016/j.mcna.2024.03.003. Epub 2024 Apr 12. Med Clin North Am. 2024. PMID: 39084843 Review.
Over the last decade, randomized clinical trials of several pharmacologic agents have demonstrated a reduction in cardiovascular mortality and other important secondary outcomes. Angiotensin-Neprilysin Inhibitors and Sodium-Glucose Co-transporter 2 inhibitors have now beco …
Over the last decade, randomized clinical trials of several pharmacologic agents have demonstrated a reduction in cardiovascular mort …
Metabolites predict cardiovascular disease events in persons living with HIV: a pilot case-control study.
Okeke NL, Craig DM, Muehlbauer MJ, Ilkayeva O, Clement ME, Naggie S, Shah SH. Okeke NL, et al. Metabolomics. 2018 Mar;14(3):23. doi: 10.1007/s11306-018-1318-z. Epub 2018 Jan 31. Metabolomics. 2018. PMID: 30760970 Free PMC article.
INTRODUCTION: Persons living with HIV (PLWH) are at higher risk for cardiovascular disease (CVD) events than uninfected persons. Current risk-stratification methods to define PLWH at highest risk for CVD events are lacking. ...RESULTS: Factors derived from short-cha …
INTRODUCTION: Persons living with HIV (PLWH) are at higher risk for cardiovascular disease (CVD) events than uninfected person …
4,291 results